Skip to main content
. 2024 May 4;13(6):1253–1268. doi: 10.1007/s40121-024-00970-x

Fig. 3.

Fig. 3

AZD7442 serum concentrations by participant ADA status in a PROVENT and b STORM CHASER. ADA antidrug antibody, %CV percent geometric coefficient of variation, TE-ADA treatment-emergent ADA